823513
TSKgel® FcR-IIIA-NPR (5 µm) HPLC Columns
L x I.D. 7.5 cm × 4.6 mm, Glycoprotein phase
About This Item
Recommended Products
product name
TSKgel® FcR-IIIA-NPR HPLC Column, PEEK, L × I.D. 7.5 cm × 4.6 mm, 5 μm particle size
ligand
(modified recombinant FcyRIIIA)
material
PEEK
product line
TSKgel®
technique(s)
HPLC: suitable
L × I.D.
7.5 cm × 4.6 mm
matrix
polymethacrylate
matrix active group
Glycoprotein phase
particle size
5 μm
operating pH range
4.0-8.0
separation technique
affinity
storage temp.
2-8°C
Legal Information
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Sorry, we don't have COAs for this product available online at this time.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Fast assessment of antibody-dependent cell-mediated cytotoxicity (ADCC) and glycoform pattern of a therapeutic antibody rituximab by FcγRIIIa affinity chromatography.
Fast assessment of antibody-dependent cell-mediated cytotoxicity (ADCC) and glycoform pattern of a therapeutic antibody rituximab by FcγRIIIa affinity chromatography.
Fast assessment of antibody-dependent cell-mediated cytotoxicity (ADCC) and glycoform pattern of a therapeutic antibody rituximab by FcγRIIIa affinity chromatography.
Fast assessment of antibody-dependent cell-mediated cytotoxicity (ADCC) and glycoform pattern of a therapeutic antibody rituximab by FcγRIIIa affinity chromatography.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service